{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:10:08Z","timestamp":1749204608458,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00108-025-01902-8","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T16:55:20Z","timestamp":1747068920000},"page":"639-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wird es doch eine medikament\u00f6se Therapie der OSA geben?","Can drug therapy for obstructive sleep apnea be expected after all?"],"prefix":"10.1007","volume":"66","author":[{"given":"Ingo","family":"Fietze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"8","key":"1902_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","volume":"7","author":"AV Benjafield","year":"2019","unstructured":"Benjafield\u00a0AV, Ayas\u00a0NT, Eastwood\u00a0PR, Heinzer\u00a0R, Ip\u00a0MSM, Morrell\u00a0MJ, Nunez\u00a0CM, Patel\u00a0SR, Penzel\u00a0T, P\u00e9pin\u00a0JL, Peppard\u00a0PE, Sinha\u00a0S, Tufik\u00a0S, Valentine\u00a0K, Malhotra\u00a0A (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a\u00a0literature-based analysis. Lancet Respir Med 7(8):687\u2013698","journal-title":"Lancet Respir Med"},{"issue":"5","key":"1902_CR2","doi-asserted-by":"publisher","first-page":"e12770","DOI":"10.1111\/jsr.12770","volume":"28","author":"I Fietze","year":"2019","unstructured":"Fietze\u00a0I, Laharnar\u00a0N, Obst\u00a0A, Ewert\u00a0R, Felix\u00a0SB, Garcia\u00a0C, Gl\u00e4ser\u00a0S, Glos\u00a0M, Schmidt\u00a0CO, Stubbe\u00a0B, V\u00f6lzke\u00a0H, Zimmermann\u00a0S, Penzel\u00a0T (2019) Prevalence and association analysis of obstructive sleep apnea with gender and age differences\u2014Results of SHIP-Trend. J\u00a0Sleep Res 28(5):e12770. https:\/\/doi.org\/10.1111\/jsr.12770","journal-title":"J Sleep Res"},{"issue":"1","key":"1902_CR3","doi-asserted-by":"publisher","first-page":"15015","DOI":"10.1038\/nrdp.2015.15","volume":"25","author":"P L\u00e9vy","year":"2015","unstructured":"L\u00e9vy\u00a0P, Kohler\u00a0M, McNicholas\u00a0WT, Barb\u00e9\u00a0F, McEvoy\u00a0RD, Somers\u00a0VK, Lavie\u00a0L, P\u00e9pin\u00a0JL (2015) Obstructive sleep apnoea syndrome. Nat Rev Dis Primers 25(1):15015. https:\/\/doi.org\/10.1038\/nrdp.2015.15","journal-title":"Nat Rev Dis Primers"},{"doi-asserted-by":"crossref","unstructured":"Baldanci et al (2023) OSA is associated with the human gut microbiota composition and functional potential in the population-based Swedish cardio-pulmonary bioImage study. Chest 164(2)","key":"1902_CR4","DOI":"10.1016\/j.chest.2023.03.010"},{"issue":"2","key":"1902_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5664\/jcsm.11378","volume":"21","author":"MR Wilson","year":"2025","unstructured":"Wilson\u00a0MR, Carroll\u00a0R, Kinder\u00a0S, Ryan\u00a0A, Hukins\u00a0CA, Duce\u00a0B, Ellender\u00a0CM (2025) Prospective crossover trial of positional and CPAP therapy for the treatment of mild-to-moderate positional obstructive sleep apnea. J\u00a0Clin Sleep Med 21(2):305\u2013313","journal-title":"J Clin Sleep Med"},{"unstructured":"https:\/\/www.g-ba.de\/richtlinien\/127\/","key":"1902_CR6"},{"key":"1902_CR7","doi-asserted-by":"publisher","first-page":"44392","DOI":"10.1038\/srep44392","volume":"7","author":"FT Curado","year":"2017","unstructured":"Curado\u00a0FT, Fishbein\u00a0K, Pho\u00a0H, Brennick\u00a0M, Dergacheva\u00a0O, Sennes\u00a0LU, Pham\u00a0LV, Ladenheim\u00a0EE, Spencer\u00a0R, Mendelowitz\u00a0D, Schwartz\u00a0AR, Polotsky\u00a0VY (2017) Chemogenetic stimulation of the hypoglossal neurons improves upper airway patency. Sci Rep 7:44392. https:\/\/doi.org\/10.1038\/srep44392","journal-title":"Sci Rep"},{"issue":"12","key":"1902_CR8","doi-asserted-by":"publisher","first-page":"zsad226","DOI":"10.1093\/sleep\/zsad226","volume":"46","author":"FL Knapman","year":"2023","unstructured":"Knapman\u00a0FL, Cohen\u00a0EM, Kulaga\u00a0T, Lovell\u00a0N, Lisowski\u00a0L, McMullan\u00a0S, Burke\u00a0PGR, Bilston\u00a0LE (2023) Direct optogenetic activation of upper airway muscles in an acute model of upper airway hypotonia mimicking sleep onset. Sleep 46(12):zsad226. https:\/\/doi.org\/10.1093\/sleep\/zsad226","journal-title":"Sleep"},{"issue":"4","key":"1902_CR9","doi-asserted-by":"publisher","first-page":"e228212","DOI":"10.1001\/jamanetworkopen.2022.8212","volume":"5","author":"A Carneiro-Barrera","year":"2022","unstructured":"Carneiro-Barrera\u00a0A, Amaro-Gahete\u00a0FJ, Guill\u00e9n-Riquelme\u00a0A, Jurado-Fasoli\u00a0L, S\u00e1ez-Roca\u00a0G, Mart\u00edn-Carrasco\u00a0C, Buela-Casal\u00a0G, Ruiz\u00a0JR (2022) Effect of an interdisciplinary weight loss and lifestyle intervention on obstructive sleep apnea severity: the INTERAPNEA randomized clinical trial. JAMA Netw Open 5(4):e228212. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.8212","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1902_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa2301972","volume":"389","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff\u00a0AM, Kaplan\u00a0LM, Fr\u00edas\u00a0JP, Wu\u00a0Q, Du\u00a0Y, Gurbuz\u00a0S, Coskun\u00a0T, Haupt\u00a0A, Milicevic\u00a0Z, Hartman\u00a0ML (2023) Triple-hormone-receptor agonist retatrutide for obesity\u2014A phase\u00a02 trial. N\u00a0Engl J Med 389(6):514\u2013526 (Retatrutide Phase\u00a02 Obesity Trial Investigators)","journal-title":"N Engl J Med"},{"key":"1902_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-025-00404-9.","author":"E Dolgin","year":"2025","unstructured":"Dolgin\u00a0E (2025) Dozens of new obesity drugs are coming: these are the ones to watch. Nature. https:\/\/doi.org\/10.1038\/d41586-025-00404-9","journal-title":"Nature"},{"issue":"8","key":"1902_CR12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ijo.2016.52","volume":"40","author":"A Blackman","year":"2016","unstructured":"Blackman\u00a0A, Foster\u00a0GD, Zammit\u00a0G, Rosenberg\u00a0R, Aronne\u00a0L, Wadden\u00a0T, Claudius\u00a0B, Jensen\u00a0CB, Mignot\u00a0E (2016) Effect of liraglutide 3.0\u202fmg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes 40(8):1310\u20131319. https:\/\/doi.org\/10.1038\/ijo.2016.52","journal-title":"Int J Obes"},{"issue":"3","key":"1902_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff\u00a0AM, Aronne\u00a0LJ, Ahmad\u00a0NN, Wharton\u00a0S, Connery\u00a0L, Alves\u00a0B, Kiyosue\u00a0A, Zhang\u00a0S, Liu\u00a0B, Bunck\u00a0MC, Stefanski\u00a0A (2022) Tirzepatide once weekly for the treatment of obesity. N\u00a0Engl J Med 387(3):205\u2013216 (SURMOUNT\u20111 Investigators)","journal-title":"N Engl J Med"},{"issue":"13","key":"1902_CR14","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","volume":"391","author":"A Malhotra","year":"2024","unstructured":"Malhotra\u00a0A, Grunstein\u00a0RR, Fietze\u00a0I, Weaver\u00a0TE, Redline\u00a0S, Azarbarzin\u00a0A, Sands\u00a0SA, Schwab\u00a0RJ, Dunn\u00a0JP, Chakladar\u00a0S, Bunck\u00a0MC, Bednarik\u00a0J (2024) Tirzepatide for the treatment of obstructive sleep apnea and obesity. N\u00a0Engl J Med 391(13):1193\u20131205. https:\/\/doi.org\/10.1056\/NEJMoa2404881 (SURMOUNT-OSA Investigators)","journal-title":"N Engl J Med"},{"issue":"5","key":"1902_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/resp.13079","volume":"22","author":"RL Horner","year":"2017","unstructured":"Horner\u00a0RL, Grace\u00a0KP, Wellmann\u00a0A (2017) A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy. Respirology 22(5):861\u2013873","journal-title":"Respirology"},{"key":"1902_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.smrv.2019.04.009","volume":"46","author":"T Gaisl","year":"2019","unstructured":"Gaisl\u00a0T, Haile\u00a0SR, Thiel\u00a0S, Osswald\u00a0M, Kohler\u00a0M (2019) Efficacy of pharmacotherapy for OSA in adults: a\u00a0systematic review and network meta-analysis. Sleep Med Rev 46:74\u201386. https:\/\/doi.org\/10.1016\/j.smrv.2019.04.009","journal-title":"Sleep Med Rev"},{"issue":"8","key":"1902_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/sleep\/29.8.1031","volume":"29","author":"TI Morgenthaler","year":"2006","unstructured":"Morgenthaler\u00a0TI, Kapen\u00a0S, Lee-Chiong\u00a0T, Alessi\u00a0C, Boehlecke\u00a0B, Brown\u00a0T, Coleman\u00a0J, Friedman\u00a0L, Kapur\u00a0V, Owens\u00a0J, Pancer\u00a0J, Swick\u00a0T (2006) Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 29(8):1031\u20131035 (Standards of Practice Committee; American Academy of Sleep Medicine)","journal-title":"Sleep"},{"unstructured":"https:\/\/aasm.org\/wp-content\/uploads\/2025\/01\/AASM_NovelDrugs.pdf","key":"1902_CR18"},{"issue":"4","key":"1902_CR19","doi-asserted-by":"publisher","first-page":"zsad009","DOI":"10.1093\/sleep\/zsad009","volume":"46","author":"O Dergacheva","year":"2023","unstructured":"Dergacheva\u00a0O, Polotsky\u00a0VY, Mendelowitz\u00a0D (2023) Oxytocin mediated excitation of hypoglossal motoneurons: implications for treating obstructive sleep apnea. Sleep 46(4):zsad9. https:\/\/doi.org\/10.1093\/sleep\/zsad009","journal-title":"Sleep"},{"issue":"1","key":"1902_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5664\/jcsm.10256","volume":"19","author":"TJ Altree","year":"2023","unstructured":"Altree\u00a0TJ, Aishah\u00a0A, Loffler\u00a0KA, Grunstein\u00a0RR, Eckert\u00a0DJ (2023) The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a\u00a0double-blind, placebo-controlled, randomized crossover trial. J\u00a0Clin Sleep Med 19(1):85\u201396","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"1902_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1513\/AnnalsATS.202206-492OC","volume":"20","author":"A Aishah","year":"2023","unstructured":"Aishah\u00a0A, Loffler\u00a0KA, Toson\u00a0B, Mukherjee\u00a0S, Adams\u00a0RJ, Altree\u00a0TJ, Ainge-Allen\u00a0HW, Yee\u00a0BJ, Grunstein\u00a0RR, Carberry\u00a0JC, Eckert\u00a0DJ (2023) One month dosing of atomoxetine plus oxybutynin in obstructive sleep apnea: a\u00a0randomized, placebo-controlled trial. Ann Am Thorac Soc 20(4):584\u2013595","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"1902_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.chest.2021.08.080","volume":"161","author":"E Perger","year":"2022","unstructured":"Perger\u00a0E, Taranto Montemurro\u00a0L, Rosa\u00a0D, Vicini\u00a0S, Marconi\u00a0M, Zanotti\u00a0L, Meriggi\u00a0P, Azarbarzin\u00a0A, Sands\u00a0SA, Wellman\u00a0A, Lombardi\u00a0C, Parati\u00a0G (2022) Reboxetine plus oxybutynin for OSA treatment: a\u00a01-week, randomized, placebo-controlled, double-blind crossover trial. Chest 161(1):237\u2013247","journal-title":"Chest"},{"issue":"4","key":"1902_CR23","doi-asserted-by":"publisher","first-page":"zsy261","DOI":"10.1093\/sleep\/zsy261","volume":"42","author":"R Lim","year":"2019","unstructured":"Lim\u00a0R, Carberry\u00a0JC, Wellman\u00a0A, Grunstein\u00a0R, Eckert\u00a0DJ (2019) Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals. Sleep 42(4):zsy261. https:\/\/doi.org\/10.1093\/sleep\/zsy261","journal-title":"Sleep"},{"issue":"5","key":"1902_CR24","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1183\/13993003.00823-2016","volume":"48","author":"L Taranto-Montemurro","year":"2016","unstructured":"Taranto-Montemurro\u00a0L, Sands\u00a0SA, Edwards\u00a0BA, Azarbarzin\u00a0A, Marques\u00a0M, de Melo\u00a0C, Eckert\u00a0DJ, White\u00a0DP, Wellman\u00a0A (2016) Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation. Eur Respir\u00a0J 48(5):1340\u20131350","journal-title":"Eur Respir J"},{"issue":"10","key":"1902_CR25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1164\/rccm.201808-1493OC","volume":"199","author":"L Taranto-Montemurro","year":"2019","unstructured":"Taranto-Montemurro\u00a0L, Messineo\u00a0L, Sands\u00a0SA, Azarbarzin\u00a0A, Marques\u00a0M, Edwards\u00a0BA, Eckert\u00a0DJ, White\u00a0DP, Wellman\u00a0A (2019) The combination of atomoxetine and Oxybutynin greatly reduces obstructive sleep apnea severity. A\u00a0randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med 199(10):1267\u20131276","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1902_CR26","doi-asserted-by":"publisher","first-page":"zsx184","DOI":"10.1093\/sleep\/zsx184","volume":"41","author":"DW Carley","year":"2018","unstructured":"Carley\u00a0DW, Prasad\u00a0B, Reid\u00a0KJ, Malkani\u00a0R, Attarian\u00a0H, Abbott\u00a0SM, Vern\u00a0B, Xie\u00a0H, Yuan\u00a0C, Zee\u00a0PC (2018) Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: effects of dronabinol in obstructive sleep apnea. Sleep 41(1):zsx184. https:\/\/doi.org\/10.1093\/sleep\/zsx184","journal-title":"Sleep"},{"issue":"12","key":"1902_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1164\/rccm.202109-2043OC","volume":"205","author":"J Hedner","year":"2022","unstructured":"Hedner\u00a0J, Stenl\u00f6f\u00a0K, Zou\u00a0D, Hoff\u00a0E, Hansen\u00a0C, Kuhn\u00a0K, Lennartz\u00a0P, Grote\u00a0L (2022) A randomized controlled clinical trial exploring safety and tolerability of sulthiame in sleep apnea. Am J Respir Crit Care Med 205(12):1461\u20131469","journal-title":"Am J Respir Crit Care Med"},{"key":"1902_CR28","doi-asserted-by":"publisher","first-page":"zsae276","DOI":"10.1093\/sleep\/zsae276","volume":"26","author":"J Walsh","year":"2024","unstructured":"Walsh\u00a0J, Rankin\u00a0T, Mehra\u00a0S, Naughton\u00a0MT, Roebuck\u00a0T, McDermott\u00a0E, Pattichis\u00a0A, Smith\u00a0R, Walsh\u00a0R, Bleackley\u00a0M, Maddison\u00a0K, O\u2019Brien\u00a0TJ (2024) A randomised dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnoea. Sleep 26:zsae276. https:\/\/doi.org\/10.1093\/sleep\/zsae276","journal-title":"Sleep"},{"issue":"7","key":"1902_CR29","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.5664\/jcsm.10528","volume":"19","author":"L Messineo","year":"2023","unstructured":"Messineo\u00a0L, Norman\u00a0D, Ojile\u00a0J (2023) The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a\u00a0dose-escalating, open-label trial. J\u00a0Clin Sleep Med 19(7):1183\u20131190","journal-title":"J Clin Sleep Med"},{"doi-asserted-by":"crossref","unstructured":"Osman AM, Mukherjee S, Altree TJ, Delbeck M, Gehring D, Hahn M, Lang T, Xing C, Muller T, Weimann G, Eckert DJ\u00a0 \u00a0(2023) Topical potassium channel blockage improves pharyngeal collapsibility: A translational, placebo-controlled trial. Chest. 2023 163(4):953\u2013965","key":"1902_CR30","DOI":"10.1016\/j.chest.2022.11.024"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01902-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:47:55Z","timestamp":1749203275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01902-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1902"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01902-8","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"2 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"I. Fietze weist auf folgende Beziehungen hin: Berater f\u00fcr Bioprojet, Lilly und Idorsia; wissenschaftliche Vortr\u00e4ge f\u00fcr Bioprojet, Idorsia, Lilly und ResMed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}